249 related articles for article (PubMed ID: 11122826)
1. Gene therapy in lung cancer.
Swisher SG; Roth JA
Curr Oncol Rep; 2000 Jan; 2(1):64-70. PubMed ID: 11122826
[TBL] [Abstract][Full Text] [Related]
2. p53 Gene therapy for lung cancer.
Swisher SG; Roth JA
Curr Oncol Rep; 2002 Jul; 4(4):334-40. PubMed ID: 12044243
[TBL] [Abstract][Full Text] [Related]
3. Gene replacement therapy for non-small cell lung cancer: a review.
Roth JA; Grammer SF
Hematol Oncol Clin North Am; 2004 Feb; 18(1):215-29. PubMed ID: 15005290
[TBL] [Abstract][Full Text] [Related]
4. Gene Therapy for Lung Cancer.
Lara-Guerra H; Roth JA
Crit Rev Oncog; 2016; 21(1-2):115-24. PubMed ID: 27481008
[TBL] [Abstract][Full Text] [Related]
5. Gene therapy approaches for the management of non-small cell lung cancer.
Roth JA; Grammer SF; Swisher SG; Komaki R; Nemunaitis J; Merritt J; Fujiwara T; Meyn RE
Semin Oncol; 2001 Aug; 28(4 Suppl 14):50-6. PubMed ID: 11605184
[TBL] [Abstract][Full Text] [Related]
6. p53 tumor suppressor gene therapy for cancer.
Roth JA; Swisher SG; Meyn RE
Oncology (Williston Park); 1999 Oct; 13(10 Suppl 5):148-54. PubMed ID: 10550840
[TBL] [Abstract][Full Text] [Related]
7. Gene replacement strategies for treating non-small cell lung cancer.
Roth JA; Grammer SF; Swisher SG; Nemunaitis J; Merritt J; Meyn RE
Semin Radiat Oncol; 2000 Oct; 10(4):333-42. PubMed ID: 11040334
[TBL] [Abstract][Full Text] [Related]
8. A phase I study of adenovirus-mediated wild-type p53 gene transfer in patients with advanced non-small cell lung cancer.
Schuler M; Rochlitz C; Horowitz JA; Schlegel J; Perruchoud AP; Kommoss F; Bolliger CT; Kauczor HU; Dalquen P; Fritz MA; Swanson S; Herrmann R; Huber C
Hum Gene Ther; 1998 Sep; 9(14):2075-82. PubMed ID: 9759934
[TBL] [Abstract][Full Text] [Related]
9. Induction of p53-regulated genes and tumor regression in lung cancer patients after intratumoral delivery of adenoviral p53 (INGN 201) and radiation therapy.
Swisher SG; Roth JA; Komaki R; Gu J; Lee JJ; Hicks M; Ro JY; Hong WK; Merritt JA; Ahrar K; Atkinson NE; Correa AM; Dolormente M; Dreiling L; El-Naggar AK; Fossella F; Francisco R; Glisson B; Grammer S; Herbst R; Huaringa A; Kemp B; Khuri FR; Kurie JM; Liao Z; McDonnell TJ; Morice R; Morello F; Munden R; Papadimitrakopoulou V; Pisters KM; Putnam JB; Sarabia AJ; Shelton T; Stevens C; Shin DM; Smythe WR; Vaporciyan AA; Walsh GL; Yin M
Clin Cancer Res; 2003 Jan; 9(1):93-101. PubMed ID: 12538456
[TBL] [Abstract][Full Text] [Related]
10. Modification of tumor suppressor gene expression in non-small cell lung cancer (NSCLC) with a retroviral vector expressing wildtype (normal) p53.
Roth JA
Hum Gene Ther; 1996 May; 7(7):861-74. PubMed ID: 8860838
[No Abstract] [Full Text] [Related]
11. Gene replacement strategies for lung cancer.
Roth JA
Curr Opin Oncol; 1998 Mar; 10(2):127-32. PubMed ID: 9555535
[TBL] [Abstract][Full Text] [Related]
12. Molecular biologic features of non-small cell lung cancer. Clinical implications.
Rusch VW; Dmitrovsky E
Chest Surg Clin N Am; 1995 Feb; 5(1):39-55. PubMed ID: 7743147
[TBL] [Abstract][Full Text] [Related]
13. CT-guided intratumoral gene therapy in non-small-cell lung cancer.
Kauczor HU; Schuler M; Heussel CP; von Weymarn A; Bongartz G; Rochlitz C; Huber C; Thelen M
Eur Radiol; 1999; 9(2):292-6. PubMed ID: 10101653
[TBL] [Abstract][Full Text] [Related]
14. Intratumoral gene therapy for non-small cell lung cancer: current status and future directions.
Neyns B; Noppen M
Monaldi Arch Chest Dis; 2003; 59(4):287-95. PubMed ID: 15148838
[TBL] [Abstract][Full Text] [Related]
15. Adenovirus-mediated p53 gene transfer in advanced non-small-cell lung cancer.
Swisher SG; Roth JA; Nemunaitis J; Lawrence DD; Kemp BL; Carrasco CH; Connors DG; El-Naggar AK; Fossella F; Glisson BS; Hong WK; Khuri FR; Kurie JM; Lee JJ; Lee JS; Mack M; Merritt JA; Nguyen DM; Nesbitt JC; Perez-Soler R; Pisters KM; Putnam JB; Richli WR; Savin M; Schrump DS; Shin DM; Shulkin A; Walsh GL; Wait J; Weill D; Waugh MK
J Natl Cancer Inst; 1999 May; 91(9):763-71. PubMed ID: 10328106
[TBL] [Abstract][Full Text] [Related]
16. [Gene therapy for lung cancer].
Kataoka M; Fujiwara T; Tanaka N
Nihon Geka Gakkai Zasshi; 2002 Feb; 103(2):244-9. PubMed ID: 11904988
[TBL] [Abstract][Full Text] [Related]
17. [Molecular pathogenesis of lung cancers and the preservative therapy].
Shimizu E
Nihon Naika Gakkai Zasshi; 2004 Mar; 93(3):562-8. PubMed ID: 15052821
[No Abstract] [Full Text] [Related]
18. Gene therapy for non-small cell lung cancer: a preliminary report of a phase I trial of adenoviral p53 gene replacement.
Roth JA; Swisher SG; Merritt JA; Lawrence DD; Kemp BL; Carrasco CH; El-Naggar AK; Fossella FV; Glisson BS; Hong WK; Khurl FR; Kurie JM; Nesbitt JC; Pisters K; Putnam JB; Schrump DS; Shin DM; Walsh GL
Semin Oncol; 1998 Jun; 25(3 Suppl 8):33-7. PubMed ID: 9704675
[TBL] [Abstract][Full Text] [Related]
19. P21 gene expression as an indicator for the activity of adenovirus-p53 gene therapy in non-small cell lung cancer patients.
Boulay JL; Perruchoud AP; Reuter J; Bolliger C; Herrmann R; Rochlitz C
Cancer Gene Ther; 2000 Sep; 7(9):1215-9. PubMed ID: 11023193
[TBL] [Abstract][Full Text] [Related]
20. Gene therapy for lung cancer.
Frederiksen KS; Petri A; Abrahamsen N; Poulsen HS
Lung Cancer; 1999 Mar; 23(3):191-207. PubMed ID: 10413196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
